Cleared Traditional

K925909 - GENESIS 1, AUTOMATED CELL COUNTER, MODIFICATION

K925909 is an FDA 510(k) clearance for GENESIS 1, manufactured by Alicia Diagnostics, Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 723-day FDA review.

K925909 · Alicia Diagnostics, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1994
Decision
723d
Days
Class 2
Risk

K925909 is an FDA 510(k) clearance for the GENESIS 1, AUTOMATED CELL COUNTER, MODIFICATION. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Alicia Diagnostics, Inc. (Oviedo, US). The FDA issued a Cleared decision on October 27, 1994 after a review of 723 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Hematology submissions.

View all Alicia Diagnostics, Inc. devices

FDA 510(k) Submission Details - K925909

510(k) Number K925909 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 1992
Decision Date October 27, 1994
Days to Decision 723 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
610d slower than avg
Panel avg: 113d · This submission: 723d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 304
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K925909.
MONOCLONAL MOUSE ANTI-HUMAN B-CELL
K943284 · Dako Corp. · Nov 1994
MONOCLONAL MOUSE ANTI-HUMAN T-CELL, CD8, RPE-CONJUGATED, CLONE DK25
K944253 · Dako Corp. · Nov 1994
MONOCLONAL MOUSE ANTI-HUMAN T-CELL
K942797 · Dako Corp. · Nov 1994
AUTOCOMP(TM) SOFTWARE AND CALIBRITE(TM) BEADS
K925274 · Becton Dickinson Immunocytometry Systems · Sep 1994
FASCOUNT SYSTME
K933486 · Becton Dickinson Immunocytometry Systems · Sep 1994
SYSMEX SE-9000 AUTOMATED HEMATOLOGY ANALYZER
K936023 · Toa Medical Electronics USA, Inc. · May 1994